BRIEF-AstraZeneca Says Enhertu Approved In The EU For Breast Cancer

Reuters | Updated: 20-01-2021 12:48 IST | Created: 20-01-2021 12:47 IST

BRIEF-AstraZeneca Says Enhertu Approved In The EU For Breast Cancer — Representative Image Image Credit: ANI

AstraZeneca PLC: * ASTRAZENECA PLC - ENHERTU APPROVED IN THE EU FOR BREAST CANCER

ASTRAZENECA - ENHERTU APPROVAL BASED ON DESTINY-BREAST01 PHASE II TRIAL * ASTRAZENECA - FOLLOWING EU APPROVAL, $75M IS DUE FROM ASTRAZENECA TO DAIICHI SANKYO AS A MILESTONE PAYMENT FOR HER2-POSITIVE BREAST CANCER Source text for Eikon: Further company coverage:

TRENDING

1

Jordan’s Skills Recognition Programme Opens New Opportunities for Workers

Jordan’s Skills Recognition Programme Opens New Opportunities for Workers

Jordan

2

Latvians vote in election in shadow of drone incursions and war in Ukraine

Latvians vote in election in shadow of drone incursions and war in Ukraine

Global

3

Tennessee execution survivor Christa Pike unconscious on ventilator, lawyers say

Tennessee execution survivor Christa Pike unconscious on ventilator, lawyers...

Global

4

Israeli strike kills five in Gaza, health officials say

Israeli strike kills five in Gaza, health officials say

Global

PERSPECTIVES AND INSIGHTS

Africa, Asia and the Americas Face Intensifying Drought Under High-Emission Futures

AI Works Differently Inside SMEs: Strategic Use, Not Adoption, Tracks Agility

Who Pays, Who Maintains, Who Answers? Ghana’s Green Infrastructure Gap Comes Into Focus

Scarce Farmland Is Pushing Agriculture Toward Smarter Machines and More Skilled Labor

DevShots

Latest News

Connect us on

Facebook Twitter LinkedIn Quora Youtube

Google News RSS

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

Name

Email

Message

By submitting, you agree that we may use your email address to respond.

Web Analytics Made Easy - Statcounter